Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
05/2003
05/15/2003WO2002083926A3 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
05/15/2003WO2002058730A3 Compositions for treatment of ocular neovascularization
05/15/2003WO2002058679A3 Antiangiogenic compounds and an assay for inhibitors of cell invasion
05/15/2003WO2002040016A8 Association of calpain inhibitors and reactive oxygen species trapping agents
05/15/2003WO2002026717A8 Hydroxy acid integrin antagonists
05/15/2003US20030092891 Expressed ligand - vascular intercellular signalling molecule
05/15/2003US20030092766 Methods and compositions for modulating alpha adrenergic receptor activity
05/15/2003US20030092744 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
05/15/2003US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases
05/15/2003US20030092727 Hydroxamic and carboxylic acid derivatives
05/15/2003US20030092712 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092704 Novel arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
05/15/2003US20030092703 Caspase inhibitors and uses thereof
05/15/2003US20030092677 Glutamate receptor antagonists
05/15/2003US20030092663 Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a Th1 phenotype
05/15/2003US20030092655 Delivery system for nucleic acids
05/15/2003US20030092612 Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
05/15/2003US20030092176 Ependymal neural stem cells and method for their isolation
05/15/2003US20030092059 Human antibodies that bind human TNFalpha
05/15/2003US20030091566 Antitumor agents
05/15/2003US20030091528 Mixing an opaque mixture under pressure
05/15/2003US20030091510 Administering fungicide to mucous membrane
05/15/2003CA2789407A1 Inhibitor oligonucleotides and their use for specific repression of a gene
05/15/2003CA2669810A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2466517A1 .omega.-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/15/2003CA2466516A1 Targeting the reverse mode of the na+/ca2+ exchanger for the treatment of optic neuropathy associated with glaucoma and ischemic optic neuropathy
05/15/2003CA2466375A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
05/15/2003CA2466334A1 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
05/15/2003CA2466145A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
05/15/2003CA2466030A1 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003CA2465908A1 Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof
05/15/2003CA2465894A1 Method for treating or preventing inflammatory diseases
05/15/2003CA2465695A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2464717A1 Compounds and methods for treating transplant rejection
05/15/2003CA2464007A1 Methods for treating ocular neovascular diseases
05/14/2003EP1310498A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
05/14/2003EP1310493A1 N-adamantylalkyl benzamide derivates as p2x7-receptor antagonists
05/14/2003EP1309704A2 Regulation of human membrane-type serine protease
05/14/2003EP1309700A2 Human phosphodiesterases
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309620A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309618A2 Leucine-based motif and clostridial neurotoxins
05/14/2003EP1309609A2 Lactam compounds and their use as inhibitors of serine proteases and method
05/14/2003EP1309589A2 Urea compounds and methods of uses
05/14/2003EP1309587A1 Cinnoline compounds
05/14/2003EP1309571A1 Non-steroidal inflammation inhibitors
05/14/2003EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials
05/14/2003EP1309563A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309559A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/14/2003EP1309323A2 Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid
05/14/2003EP1309322A2 Method of treating neurodegenerative disorders of the retina and optic nerve head
05/14/2003EP1309316A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor
05/14/2003EP1180105B1 Substituted aza-oxindole derivatives
05/14/2003CN1418214A 4-Hydroxy-1, 8-Naphthyridine-3-carboxamides as antiviral agents
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418194A Amide compounds and use thereof
05/14/2003CN1418192A Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1418185A Aniline-derived ligands for thyroid receptor
05/14/2003CN1418121A Compound with 5-HT1A activity useful for treating disorders of outer retina
05/14/2003CN1418110A Remedies for sjoegrens syndrome
05/14/2003CN1418100A Compounds with 5-HT activity useful for controlling visual field loss
05/14/2003CN1418096A IL-8 receptor antagonists
05/14/2003CN1418095A Ocular growth and nicotinic antagonists
05/14/2003CN1416889A Eye ointment and its prepn
05/14/2003CN1416824A Medicament for preventing and treating myopia and asthenopia
05/14/2003CN1416811A Indomethacin liposome eye drops
05/14/2003CN1108289C Difluoroprostaglundin derivatives and their use
05/14/2003CN1108167C Shuangtian oil
05/13/2003US6562873 Containing oxy-chloro components including chlorine dioxide, hypochlorite, perchlorate or chlorite components
05/13/2003US6562846 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
05/13/2003US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies
05/13/2003US6562824 Dihydropyridine soft drugs, and related compositions and methods
05/13/2003US6562823 Inhibition of farnesyl-protein transferase has been shown to block the growth of Ras-transformed cells in soft agar
05/13/2003US6562821 For treating arthritis and related disorders, and for treating diseases associated with altered mitochondrial function
05/13/2003US6562816 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects
05/13/2003US6562811 Pyridine derivatives
05/13/2003US6562613 Recombinant C-proteinase and processes, methods and uses thereof
05/13/2003US6562381 (+)-Cycloolivil as antioxidant obtained from natural source namely stereospermum personatum
05/13/2003US6562345 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
05/13/2003CA2361906A1 Water-soluble fluorinated sulfonamides as topical carbonic anhydrase inhibitors, for treating glaucoma
05/08/2003WO2003038123A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
05/08/2003WO2003038095A2 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
05/08/2003WO2003037916A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003WO2003037899A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003WO2003037896A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists
05/08/2003WO2003037888A1 3-substituted-4-pyrimidone derivatives
05/08/2003WO2003037879A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
05/08/2003WO2003037876A1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist
05/08/2003WO2003037874A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003WO2003037873A1 Substituted benzo[b]azepin-2-one compounds
05/08/2003WO2003037863A2 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003WO2003037433A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/08/2003WO2003037361A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037350A1 New dry and aqueous epinastine-syrup-formulation
05/08/2003WO2003037349A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003WO2003037335A1 5-heteroatom-substituted pyrazoles
1 ... 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 ... 531